Xinteza Discovers Novel Key Enzyme For Cannabinoid Biosynthesis
Xinteza API Ltd., a biosynthesis technology company, revealed the discovery of a new catalytic enzyme, capable of solving one of the major bottlenecks that has so far limited the design of sustainable and cost-efficient cannabinoid biosynthesis production systems, in research led by professor Asaph Aharoni at the Weizma